Need a specific person's email?
Browse Destiny Pharma Limited - In Liquidation's employee directory (about 7 employees) and reveal verified emails free.
Destiny Pharma Limited - In Liquidation's most common email format is First.Last@destinypharma.com (ex. John.Doe@destinypharma.com), used for 43% of destinypharma.com addresses. Destiny Pharma Limited - In Liquidation uses 4 email patterns.
| Format | Example | Share of destinypharma.com |
|---|---|---|
| First.Last@destinypharma.comMost common | John.Doe@destinypharma.com | |
| FL@destinypharma.com | JD@destinypharma.com | |
| FLast@destinypharma.com | JDoe@destinypharma.com | |
| First@destinypharma.com | John@destinypharma.com |
Browse Destiny Pharma Limited - In Liquidation's employee directory (about 7 employees) and reveal verified emails free.
Biotechnology ResearchEngland, United Kingdom2-10 Employees
Destiny Pharma Limited is a biotechnology research company based in Science Park Square, Brighton, England, United Kingdom. It operates as a clinical-stage biotechnology company focused on developing novel medicines to prevent life-threatening infections, including microbiome-based biotherapeutics and XF drug assets. Its pipeline includes NTCD-M3, a Phase 3 ready treatment for preventing recurrence of Clostridioides difficile infection, and XF-73 nasal gel, which has completed a positive Phase 2b trial for preventing post-surgical staphylococcal hospital infections including MRSA. Destiny Pharma has pursued collaborations and licensing arrangements, including a Sebela Pharmaceuticals deal for NTCD-M3 and a dermal XR-73 program with China Medical Systems. The company is currently in liquidation with joint administrators and later joint liquidators appointed, and it employs between 2 and 10 people.
Most common format
First.Last@destinypharma.com
Example: John.Doe@destinypharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.